LSV Asset Management
AMPH icon

LSV Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

LSV Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
642,014
-9,700
-1% -$196K 0.02% 402
2026
Q1 		$12.8M Buy
651,714
+541,414
+491% +$13.2M 0.03% 365
2025
Q4 		$2.95M Buy
110,300
+37,000
+50% +$953K 0.01% 533
2025
Q3 		$1.95M Buy
73,300
+30,100
+70% +$777K ﹤0.01% 578
2025
Q2 		$992K Hold
43,200
– – ﹤0.01% 608
2025
Q1 		$1.25M Buy
43,200
+6,800
+19% +$217K ﹤0.01% 604
2024
Q4 		$1.35M Sell
36,400
-44,000
-55% -$2.01M ﹤0.01% 586
2024
Q3 		$3.9M Hold
80,400
– – 0.01% 526
2024
Q2 		$3.22M Sell
80,400
-144,368
-64% -$5.98M 0.01% 566
2024
Q1 		$9.87M Sell
224,768
-92,832
-29% -$4.79M 0.02% 439
2023
Q4 		$19.6M Buy
317,600
+105,232
+50% +$5.53M 0.04% 345
2023
Q3 		$9.77M Hold
212,368
– – 0.02% 425
2023
Q2 		$12.2M Buy
212,368
+179,168
+540% +$7.94M 0.03% 399
2023
Q1 		$1.25M Buy
33,200
+22,500
+210% +$738K ﹤0.01% 650
2022
Q4 		$300K Hold
10,700
– – ﹤0.01% 761
2022
Q3 		$301K Sell
10,700
-116,353
-92% -$3.8M ﹤0.01% 760
2022
Q2 		$4.42M Sell
127,053
-12,700
-9% -$453K 0.01% 524
2022
Q1 		$5.02M Buy
139,753
+54,907
+65% +$1.56M 0.01% 526
2021
Q4 		$1.98M Buy
84,846
+35,546
+72% +$727K ﹤0.01% 647
2021
Q3 		$937K Buy
49,300
+18,900
+62% +$370K ﹤0.01% 719
2021
Q2 		$612K Buy
+30,400
New +$573K ﹤0.01% 764

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
Denali Advisors San Diego, California $993M AUM 34.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
LG
LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management's AMPH Position: Q2 2026 in Review

LSV Asset Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 1.5% in Q2 2026, selling an estimated $196K and leaving 642,014 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #402.

LSV Asset Management first reported a position in AMPH in Q2 2021 and has held it in 21 quarters since. The position peaked at $19.6M in Q4 2023. 89 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • LSV Asset Management held 642,014 shares of Amphastar Pharmaceuticals worth $13M as of Q2 2026.
  • LSV Asset Management sold 9,700 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $196K.
  • Amphastar Pharmaceuticals made up 0.02% of LSV Asset Management's portfolio in Q2 2026, its #402 holding.
  • LSV Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • LSV Asset Management's Amphastar Pharmaceuticals position peaked at $19.6M in Q4 2023.
  • 89 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.